Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHA:605199)
China flag China · Delayed Price · Currency is CNY
5.72
+0.08 (1.42%)
Jul 30, 2026, 3:00 PM CST

SHA:605199 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-340.68-287.37-274.4610.8585.6872.14
Depreciation & Amortization
98.7398.7377.8258.8851.0348.17
Other Amortization
2.682.681.630.830.540.31
Loss (Gain) From Sale of Assets
0.050.05-0.040.080.010.09
Asset Writedown & Restructuring Costs
12.7412.740.86-0.541.83
Loss (Gain) From Sale of Investments
2.952.95-8.18-0.35-0.55-0.32
Provision & Write-off of Bad Debts
23.5823.584.0915.58-0.233.23
Other Operating Activities
278.6364.8244.4333.3522.8912.65
Change in Accounts Receivable
-50.56-50.5617.8-63.98-245.05-34.15
Change in Inventory
163.83163.83-173.06-74.9-6.06-28.79
Change in Accounts Payable
102.74102.74165.4248.19326.920.38
Change in Other Net Operating Assets
-0.08-0.08----
Operating Cash Flow
297.36136.85-149.1228.25238.71102.48
Operating Cash Flow Growth
----88.17%132.93%3005.68%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-52.07-83.67-156.23-489.2-392.32-137.62
Sale of Property, Plant & Equipment
0.010.010.070.080.260.11
Cash Acquisitions
----35.1--
Divestitures
--13.68---
Investment in Securities
-----19.540.11
Investing Cash Flow
-52.07-83.66-142.48-524.21-411.6-117.1

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-592.9735.741,140686.02464.22
Long-Term Debt Repaid
--800.59-620.52-552.39-507.52-260.53
Net Debt Issued (Repaid)
-233.83-207.69115.22588.08178.5203.68
Common Dividends Paid
-31.62-33.55-92.16-31.56-14.35-73.75
Other Financing Activities
-50.93--1.23-3.47-16.38
Financing Cash Flow
-316.38-241.2521.83553.06164.15146.32

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-71.09-188.05-269.7757.1-8.74131.7

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
245.2953.18-305.35-460.95-153.61-35.14
Free Cash Flow Growth
------
Free Cash Flow Margin
34.54%5.90%-21.60%-25.68%-10.14%-2.60%
Free Cash Flow Per Share
0.610.13-0.77-1.27-0.38-0.09
Levered Free Cash Flow
283.7697.51-188.22-516.59-206.31-52.48
Unlevered Free Cash Flow
308.56122.97-168.37-505.19-195.06-43.81

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
50.5291.14147.75133.28138.47124.58
Change in Working Capital
218.67218.674.73-90.9878.81-35.62